Comments: NJ A1136 | 2022-2023 | Regular Session

Bill Title: Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy.

Spectrum: Partisan Bill (Republican 2-0)

Status: (Introduced - Dead) 2022-01-11 - Introduced, Referred to Assembly Health Committee [A1136 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2022 New Jersey A1136 at this time.

Social Comments on NJ A1136

feedback